Yi Kathy 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Oct 30, 2020
Insider Transaction Report
Form 4
Yi Kathy
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-10-28+78,534→ 78,534 totalExercise: $9.88Exp: 2030-10-28→ Common Stock (78,534 underlying)
Footnotes (1)
- [F1]50% of this option shall vest and become exercisable on October 28, 2022, with the remainder vesting in two (2) equal annual installments thereafter.